ATM and Ataxia-telangiectasia: To examine this, we exposed a WT LCL and LCLs derived from an NBS, Ataxia-Telangiectasia (A-T) and DIAL syndrome patient to IR and used Western blotting coupled with phospho-specific antibodies to known ATM substrates to assess ATM activation in response to DNA damage.